Heydtmann Mathis, Hardie Debbie, Shields Philip L, Faint Jeff, Buckley Christopher D, Campbell James J, Salmon Michael, Adams David H
Liver Research Laboratories, Medical Research Council, Centre for Immune Regulation, University of Birmingham, Birmingham, UK.
J Immunol. 2006 Jul 1;177(1):729-38. doi: 10.4049/jimmunol.177.1.729.
In hepatitis C virus (HCV) infection the immune response is ineffective, leading to chronic hepatitis and liver damage. Primed CD8 T cells are critical for antiviral immunity and subsets of circulating CD8 T cells have been defined in blood but these do not necessarily reflect the clonality or differentiation of cells within tissue. Current models divide primed CD8 T cells into effector and memory cells, further subdivided into central memory (CCR7+, L-selectin+), recirculating through lymphoid tissues and effector memory (CCR7-, L-selectin-) mediating immune response in peripheral organs. We characterized CD8 T cells derived from organ donors and patients with end-stage HCV infection to show that: 1) all liver-infiltrating CD8 T cells express high levels of CD11a, indicating the effective absence of naive CD8 T cells in the liver. 2) The liver contains distinct subsets of primed CD8+ T cells including a population of CCR7+ L-selectin- cells, which does not reflect current paradigms. The expression of CCR7 by these cells may be induced by the hepatic microenvironment to facilitate recirculation. 3) The CCR7 ligands CCL19 and CCL21 are present on lymphatic, vascular, and sinusoidal endothelium in normal liver and in patients with HCV infection. We suggest that the recirculation of CCR7+/L-selectin- intrahepatic CD8 T cells to regional lymphoid tissue will be facilitated by CCL19 and CCL21 on hepatic sinusoids and lymphatics. This centripetal pathway of migration would allow restimulation in lymph nodes, thereby promoting immune surveillance in normal liver and renewal of effector responses in chronic viral infection.
在丙型肝炎病毒(HCV)感染中,免疫反应无效,导致慢性肝炎和肝损伤。致敏的CD8 T细胞对抗病毒免疫至关重要,循环CD8 T细胞的亚群已在血液中得到定义,但这些亚群不一定反映组织内细胞的克隆性或分化情况。目前的模型将致敏的CD8 T细胞分为效应细胞和记忆细胞,进一步细分为中央记忆细胞(CCR7 +、L-选择素+),通过淋巴组织再循环,以及效应记忆细胞(CCR7 -、L-选择素-),在外周器官介导免疫反应。我们对来自器官供体和终末期HCV感染患者的CD8 T细胞进行了表征,结果表明:1)所有肝浸润性CD8 T细胞均高表达CD11a,表明肝脏中几乎不存在幼稚CD8 T细胞。2)肝脏中存在不同的致敏CD8 + T细胞亚群,包括一群CCR7 + L-选择素-细胞,这与当前的模式不符。这些细胞中CCR7的表达可能由肝脏微环境诱导,以促进再循环。3)CCR7配体CCL19和CCL21存在于正常肝脏和HCV感染患者的淋巴管、血管和窦状内皮上。我们认为,肝窦和淋巴管上的CCL19和CCL21将促进CCR7 + / L-选择素-肝内CD8 T细胞向区域淋巴组织的再循环。这种向心迁移途径将允许在淋巴结中再次受到刺激,从而促进正常肝脏中的免疫监视以及慢性病毒感染中效应反应的更新。